Continuous controversy over the issue of the Stillen’s clinical usefulness test… A decision will be made after the review
Through the court’s judgment towards the Dong-A ST’s ‘Stillen’, it will temporarily keep the insurance benefit; however, the ‘Clinical Usefulness Confirmation issue will still have its sore spot exposed.
The Seoul Administrative Court, on the 13th, ruled of to revoke the Ministry of Health and W...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
